EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Harnessing transcriptional regulation of alternative end-joining to predict cancer treatment

Roderic Espín, Ferran Medina-Jover, Javier Sigüenza-Andrade, Sònia Farran-Matas, Francesca Mateo, Agnes Figueras, Rosario T Sanz, Guillermo Pablo Vicent iD, Arzoo Shabbir, Lara Ruiz-Auladell, Emilio Racionero-Andrés, Irene García und 28 weitere

NAR Cancer · 2025

DOI: 10.1093/narcan/zcaf007 ↗

Kurz gefasst

Fachartikel in der Zeitschrift NAR Cancer, 2025. Verfasst von Roderic Espín und 39 weiteren Autor:innen. Beteiligte Einrichtung: ProCURE, Catalan Institute of Oncology, L'Hospitalet del Llobregat, Barcelona 08908, Spain. Hauptthemen laut MEDLINE: DNA End-Joining Repair, Gene Expression Regulation, Neoplastic, Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 163 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: GINKGO Apac del Berguedà, European Regional Development Fund, AECC.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alternative end-joining (alt-EJ) is an error-prone DNA repair pathway that cancer cells deficient in homologous recombination rely on, making them vulnerable to synthetic lethality via inhibition of poly(ADP-ribose) polymerase (PARP). Targeting alt-EJ effector DNA polymerase theta (POLθ), which synergizes with PARP inhibitors and can overcome resistance, is of significant preclinical and clinical interest. However, the transcriptional regulation of alt-EJ and its interactions with processes driving cancer progression remain poorly understood. Here, we show that alt-EJ is suppressed by hypoxia while positively associated with MYC (myelocytomatosis oncogene) transcriptional activity. Hypoxia reduces PARP1 and POLQ expression, decreases MYC binding at their promoters, and lowers PARylation and alt-EJ-mediated DNA repair in cancer cells. Tumors with HIF1A mutations overexpress the alt-EJ gene signature. Inhibition of hypoxia-inducible factor 1α or HIF1A expression depletion, combined with PARP or POLθ inhibition, synergistically reduces the colony-forming capacity of cancer cells. Deep learning reveals the anticorrelation between alt-EJ and hypoxia across regions in tumor images, and the predictions for these and MYC activity achieve area under the curve values between 0.70 and 0.86. These findings further highlight the critical role of hypoxia in modulating DNA repair and present a strategy for predicting and improving outcomes centered on targeting alt-EJ.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DNA End-Joining RepairGene Expression Regulation, NeoplasticNeoplasmsHumansPoly(ADP-ribose) Polymerase InhibitorsCell Line, TumorHypoxia-Inducible Factor 1, alpha SubunitDNA-Directed DNA PolymeraseDNA Polymerase thetaPoly (ADP-Ribose) Polymerase-1Proto-Oncogene Proteins c-myc

Substanzen

Poly(ADP-ribose) Polymerase InhibitorsHypoxia-Inducible Factor 1, alpha SubunitDNA-Directed DNA PolymeraseDNA Polymerase thetaHIF1A protein, humanPoly (ADP-Ribose) Polymerase-1PARP1 protein, humanProto-Oncogene Proteins c-myc

Autor:innen und Institutionen

  • ProCURE, Catalan Institute of Oncology, L'Hospitalet del Llobregat, Barcelona 08908, Spain.
  • Oncobell, Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet del Llobregat, Barcelona 08908, Spain.
  • Department of Physiological Sciences, University of Barcelona, L'Hospitalet del Llobregat, Barcelona 08908, Spain.
  • Molecular Biology Institute of Barcelona, Spanish National Research Council (IBMB-CSIC), Barcelona 08028, Spain.
  • Girona Biomedical Research Institute (IDIBGI), Salt, Girona 17190, Spain.
  • Regenerative Medicine Program and Program for Clinical Translation of Regenerative Medicine in Catalonia-P-CMR[C], Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet del Llobregat, Barcelona 08908, Spai…

ORCID-Profile: Guillermo Pablo Vicent, Miguel Angel Pardo-Cea

Förderung

  • GINKGO Apac del Berguedà
  • European Regional Development Fund
  • AECC
  • Department of Defense
  • Ministerio de Ciencia, Innovación y Universidades
  • Generalitat de Catalunya
  • AGAUR
  • Departament de Salut, Generalitat de Catalunya

Zitieren

APA

Espín, R., Medina-Jover, F., Sigüenza-Andrade, J., Farran-Matas, S., Mateo, F., Figueras, A., Sanz, R. T., Vicent, G. P., Shabbir, A., Ruiz-Auladell, L., Racionero-Andrés, E., García, I., Baiges, A., Franco-Luzón, L., Martínez-Tebar, A., Pardo-Cea, M. A., Martínez-Iniesta, M., Wang, X. C., Cuyàs, E., …, & Pujana, M. A. (2025). Harnessing transcriptional regulation of alternative end-joining to predict cancer treatment. NAR Cancer. https://doi.org/10.1093/narcan/zcaf007

Vancouver

Espín R, Medina-Jover F, Sigüenza-Andrade J, Farran-Matas S, Mateo F, Figueras A, et al. Harnessing transcriptional regulation of alternative end-joining to predict cancer treatment. NAR Cancer. 2025. doi:10.1093/narcan/zcaf007

BibTeX
@article{Espn2025,
  author = {Espín, Roderic and Medina-Jover, Ferran and Sigüenza-Andrade, Javier and Farran-Matas, Sònia and Mateo, Francesca and Figueras, Agnes and Sanz, Rosario T and Vicent, Guillermo Pablo and Shabbir, Arzoo and Ruiz-Auladell, Lara and Racionero-Andrés, Emilio and García, Irene and Baiges, Alexandra and Franco-Luzón, Lídia and Martínez-Tebar, Adrián and Pardo-Cea, Miguel Angel and Martínez-Iniesta, María and Wang, Xieng Chen and Cuyàs, Elisabet and Menendez, Javier A and Lopez-Cerda, Marta and Muñoz, Purificacion and Richaud, Ivonne and Raya, Angel and Fabregat, Isabel and Villanueva, Alberto and Serrat, Xènia and Cerón, Julián and Alemany, Montserrat and Guix, Inés and Herencia-Ropero, Andrea and Serra, Violeta and Krishnan, Rehna and Mekhail, Karim and Hakem, Razqallah and Bruna, Jordi and Barcellos-Hoff, Mary Helen and Viñals, Francesc and Aytes, Álvaro and Pujana, Miquel Angel},
  title = {Harnessing transcriptional regulation of alternative end-joining to predict cancer treatment},
  journal = {NAR Cancer},
  year = {2025},
  doi = {10.1093/narcan/zcaf007}
}
Kostenlos starten →